IM Cannabis Corp. Files July 2024 6-K Report
Ticker: IMCC · Form: 6-K · Filed: 2024-07-29T00:00:00.000Z
Sentiment: neutral
Topics: reporting, foreign-private-issuer, sec-filing
TL;DR
IM Cannabis Corp. filed its July 6-K, confirming 20-F annual report filings.
AI Summary
IM Cannabis Corp. filed a Form 6-K on July 29, 2024, reporting for the month of July 2024. The company, headquartered in Toronto, Canada, with principal executive offices in Israel, is a foreign private issuer. This filing indicates they will file annual reports under Form 20-F.
Why It Matters
This filing provides routine updates for investors and regulatory bodies regarding IM Cannabis Corp.'s ongoing reporting obligations as a foreign private issuer.
Risk Assessment
Risk Level: low — This is a routine filing for a foreign private issuer and does not contain significant new financial or operational information.
Key Numbers
- 001-40065 — Commission File Number (Identifies the company's filing with the SEC.)
Key Players & Entities
- IM Cannabis Corp. (company) — Registrant
- 001-40065 (dollar_amount) — Commission File Number
- 20240729 (date) — Filing Date
FAQ
What is the purpose of a Form 6-K filing?
A Form 6-K is a report of foreign private issuers pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, used to provide information that the company makes or is required to make public in its home country, files or is required to file with a stock exchange, or distributes or is required to distribute to its security holders.
Which annual report form does IM Cannabis Corp. indicate it will file?
IM Cannabis Corp. indicates it will file annual reports under cover of Form 20-F.
What is the principal executive office location for IM Cannabis Corp.?
The principal executive offices are located at Kibbutz Glil Yam, Central District, Israel.
What is the filing date of this Form 6-K?
The filing date of this Form 6-K is July 29, 2024.
What is the SIC code for IM Cannabis Corp.?
The Standard Industrial Classification (SIC) code for IM Cannabis Corp. is 2833, which corresponds to Medicinal Chemicals & Botanical Products.
Filing Stats: 341 words · 1 min read · ~1 pages · Grade level 17.2 · Accepted 2024-07-29 08:44:28
Filing Documents
- zk2431736.htm (6-K) — 10KB
- exhibit_99-1.htm (EX-99.1) — 10KB
- 0001178913-24-002343.txt ( ) — 21KB
From the Filing
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of July 2024 Commission File Number: 001-40065 IM Cannabis Corp. (Exact Name of Registrant as Specified in Charter) Kibbutz Glil Yam, Central District, Israel 4690500 (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F. Form 20-F Form 40-F Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ____ Note : Regulation S-T Rule 101(b)(1) only permits the submission in paper of a Form 6-K if submitted solely to provide an attached annual report to security holders. Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ____ Note : Regulation S-T Rule 101(b)(7) only permits the submission in paper of a Form 6-K if submitted to furnish a report or other document that the registrant foreign private issuer must furnish and make public under the laws of the jurisdiction in which the registrant is incorporated, domiciled or legally organized (the registrant's "home country"), or under the rules of the home country exchange on which the registrant's securities are traded, as long as the report or other document is not a press release, is not required to be and has not been distributed to the registrant's security holders, and, if discussing a material event, has already been the subject of a Form 6-K submission or other Commission filing on EDGAR. SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. IM CANNABIS CORP. (Registrant) Date: July 29, 2024 By: /s/ Oren Shuster Name: Oren Shuster Title: Chief Executive Officer and Director EXHIBIT INDEX 99.1 News Release dated July 29, 2024